Radiotherapy Types for High Risk Breast Cancer

Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer

Recruiting N/A Interventional Study
Breast Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
1,494 (estimated)
Sponsor
Fudan University · Other
Who this trial is looking for

This trial is looking for women aged 18 to 75 who have been treated for high risk breast cancer with surgery. Participants will compare two types of radiation therapy to see how effective they are and what side effects they may have.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a female
  • I am between 18 and 75 years old
  • I have been diagnosed with invasive breast cancer
  • I have had a mastectomy and lymph node removal
  • I have negative surgical margins
  • I have certain risk factors related to my cancer
  • I have no distant cancer spread
  • I am fit for radiation therapy

You may not be able to join if

  • I have had another cancer besides certain skin cancers
  • I have had previous radiation therapy to my chest
  • I have serious health issues with my heart or breathing
  • I have conditions that prevent me from having radiation therapy
  • I do not have the necessary risk factors for my cancer stage
  • I have known spread of cancer to other areas
  • I have bilateral breast cancer or past invasive cancer on the other side
  • I am pregnant or breastfeeding

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The study was designed to investigate whether hypofractionated adjuvant radiotherapy is noninferior to conventionally fractionated adjuvant radiotherapy in terms of efficacy and toxicities for high risk breast cancer patients treated with mastectomy

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Female * Age18-75 years * Pathologically confirmed invasive breast cancer * Treated with mastectomy and axillary lymph node dissection with more than 10 resected lymph nodes. Immediate or delayed ipsilateral breast cancer reconstruction is accepted * Negative surgical margins …
Contacts

Jinli Ma, MD, PhD

+86-15221033376

jinli.ma@aliyun.com

CONTACT

Xingxing Chen, MD, PhD

+86-13585547068

xingxing@yahoo.com

CONTACT